Send us a text

Enthea's CEO Sherry Rais joins WTR's Jesse Redmond to discuss the first psychedelic-focused disruptor benefits administrator in the US, and Enthea's mission to make psychedelics-assisted therapies stating with ketamine more affordable and accessible to the many who need it.  Rais explains what inspired her to establish Enthea, and talks about the challenges and opportunities in achieving its goals.